126 related articles for article (PubMed ID: 10550164)
1. Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?
Phillips KA; Andrulis IL; Goodwin PJ
J Clin Oncol; 1999 Nov; 17(11):3653-63. PubMed ID: 10550164
[TBL] [Abstract][Full Text] [Related]
2. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
[TBL] [Abstract][Full Text] [Related]
3. Are BRCA1- and BRCA2-associated breast cancers different? Prognosis of BRCA1-associated breast cancer.
Robson M
J Clin Oncol; 2000 Nov; 18(21 Suppl):113S-8S. PubMed ID: 11060338
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women.
Noguchi S; Kasugai T; Miki Y; Fukutomi T; Emi M; Nomizu T
Cancer; 1999 May; 85(10):2200-5. PubMed ID: 10326698
[TBL] [Abstract][Full Text] [Related]
5. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
[TBL] [Abstract][Full Text] [Related]
6. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations.
Gaffney DK; Brohet RM; Lewis CM; Holden JA; Buys SS; Neuhausen SL; Steele L; Avizonis V; Stewart JR; Cannon-Albright LA
Radiother Oncol; 1998 May; 47(2):129-36. PubMed ID: 9683359
[TBL] [Abstract][Full Text] [Related]
7. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
Armes JE; Trute L; White D; Southey MC; Hammet F; Tesoriero A; Hutchins AM; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
Cancer Res; 1999 Apr; 59(8):2011-7. PubMed ID: 10213514
[TBL] [Abstract][Full Text] [Related]
8. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
9. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.
Loman N; Johannsson O; Bendahl PO; Borg A; Fernö M; Olsson H
Cancer; 1998 Jul; 83(2):310-9. PubMed ID: 9669814
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.
Phillips KA
J Clin Oncol; 2000 Nov; 18(21 Suppl):107S-12S. PubMed ID: 11060337
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations.
Turner BC; Harrold E; Matloff E; Smith T; Gumbs AA; Beinfield M; Ward B; Skolnick M; Glazer PM; Thomas A; Haffty BG
J Clin Oncol; 1999 Oct; 17(10):3017-24. PubMed ID: 10506595
[TBL] [Abstract][Full Text] [Related]
12. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations.
Pierce LJ; Strawderman M; Narod SA; Oliviotto I; Eisen A; Dawson L; Gaffney D; Solin LJ; Nixon A; Garber J; Berg C; Isaacs C; Heimann R; Olopade OI; Haffty B; Weber BL
J Clin Oncol; 2000 Oct; 18(19):3360-9. PubMed ID: 11013276
[TBL] [Abstract][Full Text] [Related]
13. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
[TBL] [Abstract][Full Text] [Related]
14. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
15. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study.
Armes JE; Egan AJ; Southey MC; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
Cancer; 1998 Dec; 83(11):2335-45. PubMed ID: 9840533
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer in carriers of BRCA1 and BRCA2 mutations: tackling a molecular and clinical conundrum.
Haber DA
J Clin Oncol; 1999 Nov; 17(11):3367-70. PubMed ID: 10550129
[No Abstract] [Full Text] [Related]
18. Clinical management of BRCA1- and BRCA2-associated breast cancer.
Karp SE
Semin Surg Oncol; 2000 Jun; 18(4):296-304. PubMed ID: 10805951
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
